APA (7th ed.) Citation

L, L., Y, S., Q, L., P, G., T, J., X, R., . . . Z, C. (2026). CYP46A1-Targeted Treatment Alleviates Long-Term White Matter Injury Following Traumatic Brain Injury by Promoting Cholesterol Metabolic Clearance and Remyelination. CNS neuroscience & therapeutics, 32(6), e70984. https://doi.org/10.1002/cns.70984

Chicago Style (17th ed.) Citation

L, Li, et al. "CYP46A1-Targeted Treatment Alleviates Long-Term White Matter Injury Following Traumatic Brain Injury by Promoting Cholesterol Metabolic Clearance and Remyelination." CNS Neuroscience & Therapeutics 32, no. 6 (2026): e70984. https://doi.org/10.1002/cns.70984.

MLA (9th ed.) Citation

L, Li, et al. "CYP46A1-Targeted Treatment Alleviates Long-Term White Matter Injury Following Traumatic Brain Injury by Promoting Cholesterol Metabolic Clearance and Remyelination." CNS Neuroscience & Therapeutics, vol. 32, no. 6, 2026, p. e70984, https://doi.org/10.1002/cns.70984.